The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza
- PMID: 2918056
- DOI: 10.1210/jcem-68-2-477
The nature of the defect in familial male pseudohermaphroditism in Arabs of Gaza
Abstract
Studies in six Arab individuals from Gaza with familial male pseudohermaphroditism (MPH) due to 17-ketoreductase deficiency revealed several metabolic aberrations associated with the disorder. Plasma LH, FSH, testosterone, and androstenedione concentrations were low in the two prepubertal patients. After hCG administration plasma androstenedione increased markedly. The four postpubertal MPH patients had very high plasma gonadotropin and androstenedione concentrations, the latter increasing further after hCG administration. Plasma testosterone concentrations in all six patients were moderately low or normal for age and increased little after hCG administration. Spermatic venous testosterone concentrations, measured in three adults, were within the normal range in two and low in one, while androstenedione concentrations were markedly elevated (15- to 32-fold) in all three patients. Kinetic analyses of progesterone and androstenedione metabolism were performed in testicular tissue of these patients and compared to the results in two control subjects. While testicular tissue from the two prepubertal patients metabolized progesterone only to androstenedione, and that to a limited extent, the tissue from the four postpubertal patients metabolized progesterone to 16 alpha- and 16 beta-hydroxyprogesterone, 17 alpha-hydroxyprogesterone, androstenedione, and testosterone and metabolized androstenedione to testosterone. The Michaelis constants of these reactions were similar in the tissue from the MPH and the control subjects. The production of 16 alpha- plus 16 beta-hydroxyprogesterone was 5.4- to 10.3-fold greater, and 17-hydroxylase activity was 5.8- to 8.1-fold lower in the testes of the postpubertal MPH patients compared to values in the control subjects. The preference of androstenedione production through the delta 4- or delta 5-pathways was examined in the testes of two adult MPH patients using an equimolar concentration of [14C]progesterone and [3H]pregnenolone as substrates. While the flow of substrates in the control testes was equal or slightly greater through the delta 4-pathway, the delta 5-pathway predominated in the testes of the MPH patients. A large amount of dehydroepiandrosterone accumulated when NAD, the cofactor for 3 beta-hydroxysteroid dehydrogenase-isomerase, was omitted, supporting the contention that androstenedione was produced in the testes of the MPH patients mainly through the delta 5-pathway. Additional support for this suggestion was the finding that the 3H/14C ratio in androstenedione and testosterone produced from both substrates was 8 times higher in the testes from MPH patients than in those from the control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism.J Steroid Biochem Mol Biol. 1992 Dec;43(8):989-1002. doi: 10.1016/0960-0760(92)90327-F. J Steroid Biochem Mol Biol. 1992. PMID: 22217844 Review.
-
Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role.J Steroid Biochem. 1983 Jul;19(1B):663-74. doi: 10.1016/0022-4731(83)90233-9. J Steroid Biochem. 1983. PMID: 6310248
-
[In vitro studies of testicular biosynthesis in 4 cases of male pseudohermaphrodism (MPH) due to testicular 17 ketoreductase defect (author's transl)].Ann Endocrinol (Paris). 1979;40(6):547-8. Ann Endocrinol (Paris). 1979. PMID: 161958 French.
-
In vitro steroid metabolic studies in testicular 17 beta-reduction deficiency.J Clin Endocrinol Metab. 1975 Dec;41(06):1136-43. doi: 10.1210/jcem-41-6-1136. J Clin Endocrinol Metab. 1975. PMID: 128561
-
Natural potent androgens: lessons from human genetic models.Baillieres Clin Endocrinol Metab. 1998 Apr;12(1):83-113. doi: 10.1016/s0950-351x(98)80478-3. Baillieres Clin Endocrinol Metab. 1998. PMID: 9890063 Review.
Cited by
-
Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.J Endocrinol Invest. 2008 Jan;31(1):85-91. doi: 10.1007/BF03345572. J Endocrinol Invest. 2008. PMID: 18296911 Review.
-
17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite.Fertil Steril. 2008 Jan;89(1):228.e13-7. doi: 10.1016/j.fertnstert.2007.02.048. Epub 2007 May 16. Fertil Steril. 2008. PMID: 17509588 Free PMC article.
-
Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency.Mol Cell Endocrinol. 2019 Jun 1;489:3-8. doi: 10.1016/j.mce.2018.11.014. Epub 2018 Nov 30. Mol Cell Endocrinol. 2019. PMID: 30508571 Free PMC article. Review.
-
46,XY Disorder of Sex Development due to 17-Beta Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Infant of Greek Origin.J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):74-78. doi: 10.4274/jcrpe.4829. Epub 2017 Jul 24. J Clin Res Pediatr Endocrinol. 2018. PMID: 28739554 Free PMC article.
-
Endocrine findings in male pseudohermaphroditism.Eur J Pediatr. 1993;152 Suppl 2:S58-61. doi: 10.1007/BF02125441. Eur J Pediatr. 1993. PMID: 8339744 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources